The FDA has ordered BioNTech to immediately halt its Phase I/II trial of malaria vaccine candidate BNT165e, pending changes.

National MS Education and Awareness Month is celebrated each year in the US in March, after having been launched in 2003 by ...

But beware. Health and Human Services Secretary Robert F. Kennedy, Jr. has called for “conflict-free” advisory committee ...

Medical has completed the integration and design enhancements of the Apex 6 Generator into a fully integrated transvascular ...

The business conducted clinical trials of new potential drug treatments on behalf of sponsor companies seeking approval from ...

Patients enroll in phase 2 oncology trials seeking access to promising new treatments, but the risk-benefit assessments and ...

On January 6, 2025, the US Food and Drug Administration (FDA) and the US Department of Health and Human Services (HHS) Office for Human ...

Promising Nonalcoholic Steatohepatitis Therapies such as AZD2693, Saroglitazar Magnesium 4 mg, Semaglutide (SEMA), Cilofexor ...

Researchers are investigating whether a common cholesterol drug could be repurposed to treat HPV-positive cervical cancer.

Upon FDA clearance of the IND application, Tiziana plans to commence a 20-patient clinical trial of two doses of Tiziana’s novel and patented therapeutic candidate, intranasal foralumab ...

Melanoma Companies are involved in targeted therapeutics development with respective active and inactive (dormant or ...